7.5.1 NEW INVESTIGATOR RECRUITMENT The Cancer Center has been very successful in recruiting new faculty members since 2002 (57 new research members are identified in a table in section 6-^ Institutional Commitment). We are requesting developmental support for two recruitments. These recruitments are included in the Cancer Center Strategic Plan, the Medical School Dean's initiative, and the Cancer Center/AHC compact. Recruitments are performed in partnership with the appropriate academic departments;for the 57 recruitments from 2003-2007, the Cancer Center partners included 1.8 departments in seven colleges. 7.5.1.1 GENETIC MECHANISMS OF CANCER USING MODEL ORGANISMS The development of mouse model organisms has been instrumental in our understanding of cancer etiology and progression. Dr. David Largaespada, using the novel sleeping beauty Iransposon system, has been at the forefront of """"""""forward"""""""" genetics for identifying cancer genes. Dr. Largaespada's expertise in mouse models of disease is recognized by the Cancer Center as he leads our Mouse Genetics shared resource; One new faculty member in Cancer Genetics will be recruited. The candidate must have a Ph.D. or M.D., and an interest in cancer genetics, cancer gene function and identification, genornics, cancer susceptibility genes, or hereditary cancer. We are searching for a faculty member with modelprganism experience. School/Department: Medical School/Genetics, Cell Biology, and Development Recruitment lead;David Largaespada, Ph.D. 7.5.1.2 MEDICAL ONCOLOGY LEADERSHIP POSITION. The growth in clinical faculty has been in solid tumor oncology. Drs. McGlave and Yee have recognized the need to recruit a new mid-career or senior level faculty member to provide academic leadership for these clinical investigators. The future of solid tumor oncology resides at the laboratory/clinical interface;any leader in this area will require a strong background in translational research. The desired candidate will be board certified in Medical Oncology. He or she will have experience and a career-interest in solid tumor oncology. Physician-scientists and clinical investigators with a research focus on translational studies would be appropriate recruits. The successful candidate will have a track-record of sustained national peer-reviewed funding. This solid tumor oncology leadership position will be supported by an endowed chair, and may include support for additional faculty recruits. Department: Medical School/Medicine Recruitment lead: Philip McGlave, M.D.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA077598-14S1
Application #
8530527
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-02-01
Budget End
2013-01-31
Support Year
14
Fiscal Year
2012
Total Cost
$2,680
Indirect Cost
$917
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Guo, Zhijun; Johnson, Veronica; Barrera, Jaime et al. (2018) Targeting cytochrome P450-dependent cancer cell mitochondria: cancer associated CYPs and where to find them. Cancer Metastasis Rev 37:409-423
Scott, Milcah C; Temiz, Nuri A; Sarver, Anne E et al. (2018) Comparative Transcriptome Analysis Quantifies Immune Cell Transcript Levels, Metastatic Progression, and Survival in Osteosarcoma. Cancer Res 78:326-337
Ho, Yen-Yi; Nhu Vo, Tien; Chu, Haitao et al. (2018) A Bayesian hierarchical model for demand curve analysis. Stat Methods Med Res 27:2038-2049
Stabile, Laura P; Farooqui, Mariya; Kanterewicz, Beatriz et al. (2018) Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer. J Thorac Oncol 13:399-412
How, Joan; Vij, Kiran R; Ebadi, Maryam et al. (2018) Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remission. Am J Hematol 93:E381-E383
Ustun, C; Brunstein, C; DeFor, T et al. (2018) Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation. Bone Marrow Transplant 53:97-100
Williams, Shelly M; Sumstad, Darin; Kadidlo, Diane et al. (2018) Clinical-scale production of cGMP compliant CD3/CD19 cell-depleted NK cells in the evolution of NK cell immunotherapy at a single institution. Transfusion 58:1458-1467
Kaizer, Alexander M; Hobbs, Brian P; Koopmeiners, Joseph S (2018) A multi-source adaptive platform design for testing sequential combinatorial therapeutic strategies. Biometrics 74:1082-1094
Li, Danni; Huang, Fangying; Zhao, Yingchun et al. (2018) Plasma lipoproteome in Alzheimer's disease: a proof-of-concept study. Clin Proteomics 15:31
Sperduto, Paul W; Deegan, Brian J; Li, Jing et al. (2018) Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool. Neuro Oncol 20:1652-1660

Showing the most recent 10 out of 1013 publications